Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Bytom

51 clinical trials in Bytom, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Bytom at a glance
51
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

51 trials in Bytom

Open in trial search
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Takeda Development Center Americas Inc.
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Emtricitabine
  • Sponsor:Novartis Pharma AG

Crohn's disease

Recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Morf-057
  • Sponsor:Morphic Therapeutic Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Merck Healthcare KGaA
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ro7790121
  • Sponsor:F. Hoffmann-La Roche AG
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Nipocalimab
  • Sponsor:Janssen Cilag International
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Allogeneic Peripheral Blood Mononuclear Cells Induced To An Early Apoptotic State
  • Sponsor:Enlivex Therapeutics Ltd.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Litifilimab
  • Sponsor:Biogen Idec Research Limited

Crohn's disease

Recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:ICOTROKINRA
  • Sponsor:Janssen Cilag International
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:ICOTROKINRA
  • Sponsor:Janssen Cilag International

Other cities in Poland

The busiest research cities in the country

All 238 cities in Poland

Clinical research in Bytom

What the registry says about research in the country

01 Autoimmune Disorders

Extensive research focusing on systemic lupus erythematosus treatments, including studies of innovative therapies like litifilimab and ianalumab. Multiple trials are evaluating new approaches to managing psoriatic arthritis and plaque psoriasis.

  • Systemic Lupus Erythematosus (SLE)
  • Psoriatic Arthritis
  • Plaque Psoriasis

Studies aim to improve disease management and patient outcomes through targeted therapies.

02 Inflammatory Conditions

Innovative research into inflammatory bowel diseases, with particular focus on Crohn's disease and ulcerative colitis treatments. Studies are evaluating novel compounds like obefazimod and NX-13 for therapeutic efficacy.

  • Crohn's Disease
  • Ulcerative Colitis
  • Polymyalgia Rheumatica

Trials emphasize both symptom management and disease modification approaches.

03 Musculoskeletal Disorders

Studies addressing knee osteoarthritis and related conditions, including innovative approaches combining weight management with joint health treatments. Research includes evaluation of new immunotherapy options.

  • Knee Osteoarthritis
  • Axial Spondyloarthritis
  • Rheumatoid Arthritis

Focus on developing treatments that improve mobility and reduce pain.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.